logo
episode-header-image
Oct 2024
27m 8s

Weight Loss Drug Ads: Good or Bad?

APOSTROPHE PODCAST NETWORK
About this episode

Companies are spending big bucks advertising weight-loss drugs like Ozempic and Rybelsus. 

This week, we’re dropping an episode of Brian Goldman’s White Coat, Black Art podcast into our feed.

We thought you might find the topic interesting. In Canada, "reminder ads" can only give the medication's name, but they can’t tell you what the drug is for. They just tell people to ask their doctor for more information. 


I join Dr. Goldman in this episode to talk about those ads.


Are those ads good – or are they bad?

We know you want to listen to all the ads in this show. On the off-chance you don’t, subscribe ad-free here.


Hosted on Acast. See acast.com/privacy for more information.

Up next
Oct 3
Die Another Day: Reviving Old Commercials
From our archives, a favourite...Occasionally, an old advertising campaign is brought back from the dead.Even if it has been off the air for decades.In this episode, we’ll discuss a recurring Coke commercial that has been called the most popular ad of all time.A much-loved beer c ... Show More
28m 46s
Sep 26
Bookmarks
Because Terry LOVES books, we do an annual Bookmarks episode. This one is from 2024.There’s never enough room to include all the great stories we find in our research books.So this episode is dedicated to all those stories that didn’t fit into our regular episodes. The theme is “ ... Show More
28m 2s
Sep 19
The Gong Show: Ads That Could Never (Ever) Run Today
In this episode, we go back in advertising history and take a look at the ads and commercials that could never, ever, EVER run today.They are either so politically incorrect, so sexist, or so inappropriate, you won’t believe your ears.From doctors recommending cigarettes, to 7-Up ... Show More
26m 59s
Recommended Episodes
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Mar 2025
The State of Weight-Loss Drugs
$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big- ... Show More
30m 7s
Jan 2025
Can Weight Loss Drugs Impact Your Joy of Food?
Yes, drugs like Ozempic, Wegovy, and Mounjaro can help people lose weight, but at what cost? Dr. Sanjay Gupta explores why these drugs may not be the right fit for everyone. Learn more about your ad choices. Visit podcastchoices.com/adchoices 
27m 25s
Nov 2023
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond. Learn more about your ad choices. Visit megaphone.fm/adchoices 
26m 30s
Sep 2023
2. The drug behind Europe's most valuable company
How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discove ... Show More
56m 39s
Jan 2024
Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay Gupta turns to Yale School of Medicine assistant professor Dr. Jorge Moreno to explain the science behind these medications – ... Show More
30m 13s
Feb 2024
The obesity drug craze is entering its next phase
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ... Show More
22m 46s
Apr 2023
Encore: Diet Wars | Dieting 3.0 | 5
First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ... Show More
39m 12s
Oct 2024
249 - Is Ozempic Cheating?
Are weight loss drugs like Ozempic cheating? In this episode, Maggie and Ryan discuss the pros and cons of GLP-1 medications for weight loss. They explore common concerns, including muscle loss, long-term effects, and what happens when you stop taking these drugs. They also talk ... Show More
30m 25s
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s